Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens.

TO THE EDITOR: Clonal hematopoiesis of indeterminate potential (CHIP) describes an expansion of hematopoietic stem cells that harbor somatic mutations[1][1][⇓][2][⇓][3][⇓][4]-[5][5] without an underlying hematologic malignancy or definitive morphologic evidence of dysplasia.[6][6] CHIP can

[1]  M. Ladanyi,et al.  Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. , 2017, Cell stem cell.

[2]  M. Dubé,et al.  DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. , 2017, Blood.

[3]  Erika J. Thompson,et al.  Pre-leukemic clonal hematopoiesis and the risk of therapy-related myeloid neoplasms: a case-control study , 2016, The Lancet. Oncology.

[4]  Max Jan,et al.  Clonal hematopoiesis. , 2017, Seminars in hematology.

[5]  H. McLeod,et al.  Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study. , 2017, The Lancet. Oncology.

[6]  Howard Kaufman,et al.  Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers , 2016, The oncologist.

[7]  T. Druley,et al.  Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults , 2016, Nature Communications.

[8]  A. Hofman,et al.  Uncompromised 10-year survival of oldest old carrying somatic mutations in DNMT3A and TET2. , 2016, Blood.

[9]  J. Witte,et al.  MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance. , 2015, Blood.

[10]  B. Ebert,et al.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.

[11]  E. Zeggini,et al.  Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis , 2015, Cell reports.

[12]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[13]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[14]  Joshua F. McMichael,et al.  Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.

[15]  Mithat Gonen,et al.  Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.

[16]  N. Harris,et al.  MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. , 2012, The New England journal of medicine.